The 12 closest competitors and alternatives to Formation Bio among biotech companies — ranked by similarity to what Formation Bio actually does, not by market-cap band.
Subscribe to see Formation Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Formation Bio is a U.S.-based technology and drug-development company, formerly known as TrialSpark, that uses AI and software to help pharmaceutical companies develop medicines more efficiently. It serves biopharmaceutical partners by supporting clinical-trial operations and other parts of the drug-development process.
Formation Bio is a biotech company headquartered in United States. Xcout tracks 12 named people at Formation Bio, including JeanYves Fromonot (Responsable pédagogique et développement Formateur en création d'activité). Xcout recorded 43 job postings from Formation Bio in the last 90 days, naming tools such as Claude Code, PyTorch, TensorFlow.
6 more named people on record for Formation Bio, with roles, board committees and tenure — see the full roster →
Xcout recorded 43 job postings from Formation Bio in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Formation Bio's hiring signals →
Ranked by semantic similarity — how close each company is to Formation Bio by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
PhaseV uses causal machine learning and generative AI to optimize clinical trial designs and improve drug development processes.
Similar biotech company
Owkin builds artificial intelligence solutions to automate biopharmaceutical research and development and support clinical research. Its core product, K Pro, is an AI agent that analyzes multimodal patient data to generate insights, inform decision-making, and assist biopharma and healthcare professionals.
Similar biotech company
VeriSIM Life provides an AI-driven drug discovery and development platform called BIOiSIM that uses mechanistic and quantitative methods to predict patient outcomes and de-risk clinical trials. The company serves pharmaceutical companies, biotechnology firms, and academic research institutions by generating actionable insights for drug repurposing, safety-toxicity profiles, and efficacy predictions.
Biotechnology
Bioneex provides an AI-powered biopharma matchmaking platform that connects early-stage drug development companies with strategic biopharma partners and venture capital investors. The platform facilitates licensing agreements, co-development partnerships, and investment opportunities for its users.
Biotechnology
SwitchPoint Bio Holding, Inc. operates a platform that combines precision epigenomics and artificial intelligence to analyze cellular biology from blood samples. The company provides biomarker discovery, patient stratification, and treatment response mechanism readouts to support drug development and clinical research.
Similar biotech company
Prudentia Sciences is a technology company headquartered in Cambridge, Massachusetts. Launched with initial funding, the firm is dedicated to accelerating drug pipelines and transforming biopharmaceutical development.
Similar biotech company
Sai Life Sciences operates as a Contract Research, Development, and Manufacturing Organization (CRDMO) providing services from drug discovery to manufacturing. It serves pharmaceutical and biotech companies by offering capabilities in synthetic medicinal chemistry, biology, drug metabolism and pharmacokinetics, process development, and drug substance manufacturing.
Similar biotech company
Biorce is a biotechnology research company headquartered in Barcelona, Spain, with a team of around 180 employees. The company develops artificial intelligence platforms and operating systems designed to automate and streamline clinical trials with built-in review processes and human oversight.
Biotechnology
BioCorteX provides in-silico bridge trials for drug development to map how the microbiome affects a drug's efficacy across different populations. The company serves pharmaceutical science, regulatory, and commercial teams by determining for whom an asset works and why.
Similar biotech company
HitGen Inc. is a biopharmaceutical and contract research company that provides drug discovery services and technologies to the global pharmaceutical and biotechnology industry. It specializes in DNA-encoded library (DEL) technology, fragment-based drug discovery, structure-based drug design, and oligonucleotide-based therapeutics to discover novel small molecules and therapeutics for global clients and internal pipelines.
Biotechnology
Organoid Therapeutics, Inc. is a biotechnology contract research organization (CRO) that provides human brain tissue models, neuronal phenotyping, drug screening, and machine learning-based analytical services. The company serves pharmaceutical, biotech, and academic researchers by conducting pre-clinical research and translational studies to evaluate drug efficacy, neurotoxicity, and neurological disease models.
Biotechnology
Biotx.ai applies large-scale Mendelian randomization and causal AI to human genetics data to map causal relationships between genes and biological outcomes. The company generates datasets and AI models that assist researchers and organizations in discovering novel drug targets and improving clinical trial design across various therapeutic areas.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Formation Bioand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →